Align Technology Cash Flow from Operating Activities 2010-2023 | ALGN

Align Technology annual/quarterly cash flow from operating activities history and growth rate from 2010 to 2023. Cash flow from operating activities can be defined as a company's cash flows from operations.
  • Align Technology cash flow from operating activities for the quarter ending December 31, 2023 was $0.786B, a 38.16% increase year-over-year.
  • Align Technology cash flow from operating activities for the twelve months ending December 31, 2023 was $2.176B, a 84.3% increase year-over-year.
  • Align Technology annual cash flow from operating activities for 2023 was $0.786B, a 38.16% increase from 2022.
  • Align Technology annual cash flow from operating activities for 2022 was $0.569B, a 51.5% decline from 2021.
  • Align Technology annual cash flow from operating activities for 2021 was $1.173B, a 77.07% increase from 2020.
Align Technology Annual Cash Flow Ops
(Millions of US $)
2023 $786
2022 $569
2021 $1,173
2020 $662
2019 $747
2018 $555
2017 $439
2016 $248
2015 $238
2014 $227
2013 $186
2012 $134
2011 $130
2010 $130
2009 $74
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.439B $3.862B
Align Technology manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position. Align Technology has 2 operating segments, Clear Aligner, known as the Invisalign system and the CAD/CAM Services which is known as the iTero intra-oral scanners and OrthoCAD services.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.379B 20.59
Becton Dickinson (BDX) United States $68.292B 19.32
West Pharmaceutical Services (WST) United States $25.906B 46.43
Cardinal Health (CAH) United States $24.133B 13.80
Cooper (COO) United States $19.341B 29.27
Labcorp (LH) United States $17.753B 15.28
Henry Schein (HSIC) United States $9.553B 16.99
DENTSPLY SIRONA (XRAY) United States $5.872B 15.20
Merit Medical Systems (MMSI) United States $4.758B 26.08
Patterson (PDCO) United States $2.308B 11.06
CONMED (CNMD) United States $2.301B 20.87
STAAR Surgical (STAA) United States $2.098B 80.57
Atrion (ATRI) United States $0.819B 43.73
Lifevantage (LFVN) United States $0.086B 11.11
Pro-Dex (PDEX) United States $0.067B 33.62
Biolase (BIOL) United States $0.005B 0.00